Pulmonary Embolism (PE) Prevalence in Mexican-Mestizo Patients With Severe SARS-COV-2 (COVID-19) Pneumonia At A Tertiary-Level Hospital: A Review

Cueto-Robledo, Guillermo; Navarro-Vergara, Dulce-Iliana; Roldan-Valadez, Ernesto; García-César, Marisol; Graniel-Palafox, Luis-Eugenio; Cueto-Romero, Hector-Daniel; Perez-Calatayud, Angel-Augusto; Enriquez-García, Rocío; Casillas-Suárez, Catalina

doi:10.1016/j.cpcardiol.2022.101208

Cited by 6 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Currently, there are no consensus guidelines concerning which patients should undergo CTPA. Several studies suggest that patients should be screened for PT when presenting with otherwise unexplained respiratory deterioration, dyspnea, hemoptysis, or high D-dimer levels [ 21 ]. However, these signs are unspecific and frequently accompany severe forms of COVID-19.…”

Section: Discussionmentioning

confidence: 99%

COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study

Močibob

Susak

Šitum

et al. 2022

JCM

View full text Add to dashboard Cite

Pulmonary thrombosis (PT) is a frequent complication of COVID-19. However, the risk factors, predictive scores, and precise diagnostic guidelines on indications for CT pulmonary angiography (CTPA) are still lacking. This study aimed to analyze the clinical and laboratory characteristics associated with PT in patients with COVID-19. We conducted a cohort study of consecutively hospitalized adult patients with COVID-19 who underwent CTPA at the University Hospital for Infectious Diseases in Zagreb, Croatia between 1 April and 31 December 2021. Of 2078 hospitalized patients, 575 (27.6%) underwent CTPA. PT was diagnosed in 178 (30.9%) patients (69.6% males, median age of 61, IQR 50–69 years). The PT group had a higher CRP, LDH, D-dimer, platelets, and CHOD score. PT was more frequent in patients requiring ≥15 L O2/min (25.0% vs. 39.7%). In multivariable analysis, only D-dimer ≥ 1.0 mg/L (OR 1.78, 95%CI 1.12–2.75) and O2 ≥ 15 L (OR 1.89, 95%CI 1.26–2.84) were associated with PT. PT was not associated with in-hospital mortality. In conclusion, our data confirmed a high incidence of PT in hospitalized patients with COVID-19, however, no correlation with traditional risk factors and mortality was found. CTPA should be performed in patients requiring high-flow supplemental oxygen or those with increased D-dimer levels.

show abstract

Section: Discussionmentioning

confidence: 99%

COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study

Močibob

Susak

Šitum

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

“…The results of a multi-state hospital network (14) reveal that receiving two or three doses of a SARS-CoV-2 mRNA vaccine confers 90% protection against infection. Strengthening the immune system through vaccines reduces systemic and thrombotic complications, which lead to severe respiratory symptoms and the possible death of patients (15). SARS-CoV-2 transmission occurs mainly through the air and saliva and is associated with a risk of transmission through contact with infected patients (16,17).…”

Section: Discussionmentioning

confidence: 99%

COVID-19 during the third wave in Mexico: symptoms and vaccination as protective factor in Durango

et al. 2023

View full text Add to dashboard Cite

Introduction. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was responsible for the pandemic declared in January 2020, the impact of this virus is its high transmission rate where symptoms appear 2 to 14 days after exposure in Mexico the vaccination against SARS-CoV-2 has been very important. Objective. To evaluate the frequency of SARS-CoV-2, symptoms, and the impact of vaccination in the north of Durango State during the third wave in Mexico. Material and methods. We recruited 917 subjects from Sanitary Jurisdiction #2 (dependent on the Ministry of Health of Durango state) from October 2021 to January 2022. SARS-CoV-2 was diagnosed by RT-PCR in nasopharyngeal swabs. Symptoms and vaccination were evaluated. Results. The total incidence of positive cases was 41.66% (n=382). The presence of fever, cough, anosmia and dysgeusia is positively associated with infection (p<0.05). On the other hand, previous application of the vaccine and having contact with positive subjects 14 days prior to diagnosis yielded a protective OR with respect to the disease (OR = 0.60 and 0.50, respectively) (p<0.05). Conclusions. We observed a relationship between fever, cough, anosmia and dysgeusia with the disease. On the other hand, we observed a protective factor due to vaccination.

show abstract

Air and Thrombotic Venous Embolism in a Department of Emergency Medicine. A Literature Review

Cueto-Robledo¹,

Roldan-Valadez²,

Mendoza-Lopez³

et al. 2023

Current Problems in Cardiology

View full text Add to dashboard Cite

Pulmonary Embolism (PE) Prevalence in Mexican-Mestizo Patients With Severe SARS-COV-2 (COVID-19) Pneumonia At A Tertiary-Level Hospital: A Review

Cited by 6 publications

References 14 publications

COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study

COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study

COVID-19 during the third wave in Mexico: symptoms and vaccination as protective factor in Durango

Air and Thrombotic Venous Embolism in a Department of Emergency Medicine. A Literature Review

Contact Info

Product

Resources

About